Respiratory

Recent studies and meta-analyses have investigated the impact of PM2.5 on asthma, yet findings remain inconsistent.

A NEW clinical trial has found that the asthma drug montelukast does not shorten the duration of symptoms for mild-to-moderate COVID-19 patients compared to a placebo.

A new study has shown that dual bronchodilator therapy can help reduce exacerbations in patients with chronic obstructive pulmonary disease (COPD), with notable differences in efficacy between current and former smokers.

Detection of SARS-CoV-2 RNA on the floors of healthcare worker-only areas in hospitals is strongly associated with impending COVID-19 outbreaks in hospital wards.

Findings from ERS 2024 show that continuing anticoagulation after the acute phase of COVID-19 significantly reduces the risk of venous thromboembolism in recovering patients.

A new study has found that both indoor and outdoor air pollution significantly worsen respiratory health in patients with COPD

A study shows that brief exposure to ultrafine particles in the air raises the risk of respiratory infections in children.

A new study reveals that people with schizophrenia treated with antipsychotics face higher risks of severe respiratory infections, particularly during the COVID-19 pandemic.